Trellus Management Company LLC raised its position in shares of Danimer Scientific, Inc. (NYSE:DNMR – Get Rating) by 114.5% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 122,926 shares of the company's stock after buying an additional 65,626 shares during the quarter. Danimer Scientific comprises 0.7% of Trellus Management Company LLC's portfolio, making the stock its 26th largest position. Trellus Management Company LLC owned approximately 0.12% of Danimer Scientific worth $561,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of DNMR. SouthState Corp boosted its stake in Danimer Scientific by 280.0% during the 1st quarter. SouthState Corp now owns 5,130 shares of the company's stock valued at $30,000 after purchasing an additional 3,780 shares in the last quarter. Lazard Asset Management LLC acquired a new position in shares of Danimer Scientific in the 1st quarter valued at about $53,000. First Heartland Consultants Inc. acquired a new position in shares of Danimer Scientific in the 2nd quarter valued at about $58,000. Aspiriant LLC acquired a new position in shares of Danimer Scientific in the 1st quarter valued at about $59,000. Finally, Ergoteles LLC acquired a new position in shares of Danimer Scientific in the 1st quarter valued at about $66,000. Institutional investors and hedge funds own 44.98% of the company's stock.
Get
Danimer Scientific alerts:
Danimer Scientific Stock Performance
Danimer Scientific stock traded down $0.14 during mid-day trading on Tuesday, hitting $3.54. 14,760 shares of the company were exchanged, compared to its average volume of 1,133,018. Danimer Scientific, Inc. has a 1-year low of $3.09 and a 1-year high of $20.40. The company has a debt-to-equity ratio of 0.56, a quick ratio of 5.53 and a current ratio of 6.60. The business has a fifty day moving average of $4.61 and a 200 day moving average of $4.66.
Danimer Scientific (NYSE:DNMR – Get Rating) last released its quarterly earnings results on Tuesday, August 9th. The company reported ($0.30) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.04). Danimer Scientific had a negative net
margin of 104.97% and a negative return on equity of 19.28%. The firm had revenue of $12.70 million during the quarter. Equities analysts predict that Danimer Scientific, Inc. will post -0.82 EPS for the current fiscal year.
Insider Transactions at Danimer Scientific
In other Danimer Scientific news, CMO Scott Tuten sold 10,000 shares of the company's stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $5.06, for a total value of $50,600.00. Following the sale, the chief marketing officer now owns 464,136 shares in the company, valued at $2,348,528.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, CMO Scott Tuten sold 10,000 shares of the company's stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $5.06, for a total value of $50,600.00. Following the transaction, the chief marketing officer now owns 464,136 shares of the company's stock, valued at $2,348,528.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Stuart W. Pratt sold 75,327 shares of the company's stock in a transaction that occurred on Thursday, August 18th. The shares were sold at an average price of $5.25, for a total value of $395,466.75. Following the completion of the transaction, the director now directly owns 1,519,238 shares in the company, valued at approximately $7,975,999.50. The disclosure for this sale can be found here. Insiders sold 95,327 shares of company stock valued at $496,867 over the last quarter. Corporate insiders own 14.60% of the company's stock.
Wall Street Analyst Weigh In
Separately, Cowen lowered their price target on Danimer Scientific to $6.00 in a research note on Monday, August 15th.
Danimer Scientific Company Profile
(Get Rating)
Danimer Scientific, Inc, a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers.
Further Reading
- Get a free copy of the StockNews.com research report on Danimer Scientific (DNMR)
- Has AMD stock stock fallen too far?
- Oracle's Short-Term Pain Could Be Your Long-Term Gain
- Lucid is Looking Like a Clear EV Winner
- Still Lovin' It: Investors Keep Visiting McDonald's
- Did FedEx Just Deliver A Buying Opportunity?
Receive News & Ratings for Danimer Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danimer Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
